SCHEMBL5693528

SCHEMBL5693528

CS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2C2=CCCC=C2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.61
CYP2C9 P11712 2/20 0.60
PTGS1 P23219 2/20 0.60
PTGES O14684 1/20 0.47
HDAC3 O15379 1/20 0.47
PDPK1 O15530 1/20 0.47
CA12 O43570 1/20 0.47
PDE5A O76074 1/20 0.47
ABCB11 O95342 1/20 0.47
MT-CO2 P00403 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
LMNA P02545 1/20 0.47
CA3 P07451 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX5 P09917 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
ADRB3 P13945 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020015 0.89 PTGS2 (0.63) PTGS2CYP2C9PTGS1PTGESHDAC3
SCHEMBL4023943 0.83 PTGS2 (0.43) PTGS2CYP2C9PTGS1HDAC3HDAC4
SCHEMBL4020138 0.81 HDAC3 (0.46) PTGS2PTGS1HDAC3PDPK1HDAC4
SCHEMBL4196773 0.80 PTGS1 (0.48) PTGS2CYP2C9PTGS1PTGESHDAC3
SCHEMBL4026611 0.80 HDAC3 (0.42) PTGS2CYP2C9PTGS1HDAC3PDPK1
SCHEMBL4025699 0.80 HDAC3 (0.47) PTGS2CYP2C9PTGS1HDAC3PDPK1
SCHEMBL4185306 0.80 PTGS2 (0.40) PTGS2CYP2C9PTGS1HDAC3HDAC4
SCHEMBL5693249 0.80 PTGS2 (0.60) PTGS2CYP2C9PTGS1
SCHEMBL4021465 0.79 PTGS2 (0.47) PTGS2CYP2C9PTGS1HDAC3PDPK1
SCHEMBL4020107 0.79 MAPT (0.48) PTGS2CYP2C9PTGS1HDAC3PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1384477-B1 UTILIZATION OF PYRAZOLINE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF PROLIFERATIVE CELL DISEASES ESTEVE LABOR DR (ES) 2006-05-24 EP claimed
US-RE38963-E1 Pyrazoline derivatives, their preparation and application as medicaments LABORATORIOS DEL DR. ESTEVE (ES) 2006-01-31 US claimed
EP-1083171-B1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS ESTEVE LABOR DR (ES) 2004-04-28 EP claimed
US-6353117-B1 ANTIINFLAMMATORY ACTIVITY AND DISEASES IN WHICH CYCLOOXYGENASE-2 PLAYS A PART, WITHOUT HAVING THE GASTRIC AND RENAL TOXICITY OF THE CLASSIC NONSTEROIDAL ANTIINFLAMMATORY AGENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2002-03-05 US claimed
EP-1083171-A1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-03-14 EP claimed